Pregnancy: Animal reproduction studies have revealed no evidence of harm to the foetus.
The only adverse effect observed in animal reproductive studies was an increased incidence of abortions in monkeys at 13 times the expected exposure in man. There are no adequate and well controlled studies in pregnant women.
Meropenem (MEROMAX 500/MEROMAX 1000) should not be used in pregnancy unless the potential benefit justifies the potential risk to the foetus.
Lactation: Meropenem (MEROMAX 500/MEROMAX 1000) is detectable at very low concentrations in animal breast milk.
Meropenem (MEROMAX 500/MEROMAX 1000) should not be used in breast-feeding women unless benefit justifies the potential risk to the baby.
Other Services
Country
Account